Researchers unveiled an integrated biopsy approach combining shock-scattering micro-histotripsy with fine needle aspiration to improve sample quality for downstream pathology and biomarker analysis. The method is designed to enhance the precision and depth of cellular retrieval compared with conventional FNA, where sampling variability can compromise interpretation. The development targets a common diagnostic bottleneck: insufficient or poor-quality material can delay results or force repeat sampling. By improving tissue retrieval characteristics, the technique could expand the reliability of molecular profiling from minimally invasive procedures. If the technology progresses through translational validation, it could become a platform tool for oncology diagnostics and cytopathology labs.